These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2777522

  • 21. [Transient and steady-state electroretinograms and visual evoked potentials to pattern and uniform-field stimulation in humans].
    Nakayama M.
    Fukuoka Igaku Zasshi; 1994 Jul; 85(7):225-34. PubMed ID: 8070753
    [Abstract] [Full Text] [Related]

  • 22. Pattern-reversal visual evoked potentials in patients with human T-lymphotropic virus type 1 uveitis.
    Yukawa E, Urano T, Nakahara M, Miyata K, Matsuura T, Taketani F, Hara Y, Mochizuki M.
    Curr Eye Res; 2006 Jan; 31(1):37-42. PubMed ID: 16421018
    [Abstract] [Full Text] [Related]

  • 23. Pattern visual evoked potentials in the assessment of visual acuity in malingering.
    Gundogan FC, Sobaci G, Bayer A.
    Ophthalmology; 2007 Dec; 114(12):2332-7. PubMed ID: 17618689
    [Abstract] [Full Text] [Related]

  • 24. Simultaneous pattern-reversal electroretinograms and visual evoked potentials in diseases of the macula and optic nerve.
    Sherman J.
    Ann N Y Acad Sci; 1982 Dec; 388():214-26. PubMed ID: 6953869
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evaluating the effects of spatial frequency on migraines by using pattern-reversal visual evoked potentials.
    Shibata K, Yamane K, Iwata M, Ohkawa S.
    Clin Neurophysiol; 2005 Sep; 116(9):2220-7. PubMed ID: 16043404
    [Abstract] [Full Text] [Related]

  • 27. Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
    Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F.
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2520-7. PubMed ID: 10509645
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The pattern electroretinogram in glaucoma patients with confirmed visual field deficits.
    Hood DC, Xu L, Thienprasiddhi P, Greenstein VC, Odel JG, Grippo TM, Liebmann JM, Ritch R.
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2411-8. PubMed ID: 15980229
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of stimulus contrast on simultaneous steady-state pattern reversal electroretinogram and visual evoked response.
    Tetsuka S, Katsumi O, Mehta M, Tetsuka H, Hirose T.
    Ophthalmic Res; 1992 Jul; 24(2):110-8. PubMed ID: 1608596
    [Abstract] [Full Text] [Related]

  • 32. Induced refractive errors and pattern electroretinograms and pattern visual evoked potentials: implications for clinical assessments.
    Bartel PR, Vos A.
    Electroencephalogr Clin Neurophysiol; 1994 Jan; 92(1):78-81. PubMed ID: 7508855
    [Abstract] [Full Text] [Related]

  • 33. Pattern-stimulated visual evoked potential in dog: changes in elicited response with pattern size and calculation of visual acuity.
    Itoh Y, Maehara S, Okada K, Izumisawa Y.
    J Vet Med Sci; 2010 Nov; 72(11):1449-53. PubMed ID: 20644341
    [Abstract] [Full Text] [Related]

  • 34. The influence of pattern size on amplitude, latency and wave form of retinal and cortical potentials elicited by checkerboard pattern reversal and stimulus onset-offset.
    Török B, Meyer M, Wildberger H.
    Electroencephalogr Clin Neurophysiol; 1992 Nov; 84(1):13-9. PubMed ID: 1370399
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pattern visual evoked potentials and pattern electroretinograms in hypothyroidism.
    Holder GE, Condon JR.
    Doc Ophthalmol; 1989 Oct; 73(2):127-31. PubMed ID: 2638622
    [Abstract] [Full Text] [Related]

  • 37. Maturation of human visual evoked potentials: 27 weeks conceptional age to 2 years.
    Kos-Pietro S, Towle VL, Cakmur R, Spire JP.
    Neuropediatrics; 1997 Dec; 28(6):318-23. PubMed ID: 9453029
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.